产品名称
Anti-Hepatitis C Virus Antibody, NS5A, Chemicon®, from mouse
biological source
mouse
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
isotype
IgG1
shipped in
wet ice
Quality Level
Application
ELISA
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Hepatitis C Virus Antibody, NS5A is validated for use in ELISA, IF, WB, IH for the detection of Hepatitis C Virus.
Biochem/physiol Actions
Specific to HCV NS5A
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Immunogen
Recombinant protein to NS5A
Physical form
Format: Purified
Liquid 0.02M PB, 0.25M NaCl, 0.1% sodium azide
Preparation Note
Store at 2 to 8°C for up to 12 months from date of receipt.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Enhanced Ca2+ leak from ER Ca2+ stores induced by hepatitis C NS5A protein.
Lisbeth C Robinson, Jonathan S Marchant, Lisbeth C Robinson, Jonathan S Marchant
Biochemical and biophysical research communications null
Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme.
Chang Ho Lee,Ji Hyun Kim,Hee Won Kim,Heejoon Myung,Seong-Wook Lee
Nucleic Acid Therapeutics null
Azhar Mehmood et al.
Viral immunology, 30(8), 568-575 (2017-09-06)
Hepatitis C Virus (HCV) infection is a major health concern worldwide. The presence of both HCV viral RNA and NS5A proteins in peripheral blood mononuclear cells (PBMCs) indicate the efficacy of the treatment during sustained virological response (SVR) and end
Chang Ho Lee et al.
Molecular therapy. Nucleic acids, 4, e254-e254 (2015-10-07)
Hepatitis C virus (HCV) is the major cause of progressive liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Previously, we reported that a 29 nucleotide-long 2'-F pyrimidine modified RNA aptamer against the HCV nonstructural protein 5B efficiently inhibited
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee, CH; Lee, YJ; Kim, JH; Lim, JH; Kim, JH; Han, W; Lee, SH; Noh, GJ; Lee, SW
Journal of virology null
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持